PERSPECTA

News from every angle

← Back to headlines

Quantum BioPharma Reaches Midpoint Enrollment Milestone in MS Imaging Study

Quantum BioPharma has announced that it has reached a midpoint enrollment milestone in its ongoing MS imaging study.

18 May, 17:57 — 18 May, 17:57
PostShare

Sources

Showing 1 of 1 sources
globe-and-mailHigh8d ago

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Reports Midpoint Enrollment Milestone in MS Imaging Study - The Globe and Mail

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Reports Midpoint Enrollment Milestone in MS Imaging Study  The Globe and Mail

Read full article →

Related Stories

Extreme Training: What Heat Training Does to the Body

just now

Fatal Chemical Tank Implosion at US Paper Mill Leaves One Dead, Nine Missing

1h ago

Hundreds of Children Die as Measles Cases Soar in Bangladesh

1h ago

Chemical Leak and Tank Collapse at Washington State Paper Mill Kills Workers

1h ago